临床试验材料和耗材市场规模、份额、成长分析，按服务、按阶段、按类型、按治疗领域、按地区 - 行业预测，2025-2032

2023年临床试验材料和耗材的全球市场规模预计为35亿美元，从2024年的38.4亿美元增长到2032年的81.2亿美元，在预测期内（2025-2032年）预计将以2018 年复合年成长率为9.8%）。

管理临床试验用品对于避免缺货和生产过剩等问题至关重要，尤其是在药物检测成本增加的情况下。有效的供应链管理对于临床研究至关重要，并且必须解决基础设施限制和严格的法规。主要市场驱动因素包括临床试验的扩展和复杂性。临床试验用品包括输液帮浦、雾化器、针头等多种设备，对于心血管、神经、肿瘤、肺部领域疾病的评估和治疗至关重要。药物开发商和製造商越来越多地外包耗材，以确保及时交付到临床实验试验场所。此外，技术进步、解决方案提供者的策略性成长以及专利到期日的增加都刺激了对临床试验材料的需求，并促进了市场的强劲成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 供应链分析
• 技术分析
• 监管分析

临床试验材料与耗材市场规模：依服务分类

• 市场概况
• 物流/配送
• 储存和保留
• 包装标籤百叶窗
• 製造业
• 比较采购
• 其他服务

临床试验材料与耗材市场规模：依阶段

• 市场概况
• 第一阶段
• 第二阶段
• 第三阶段
• 第四阶段
• 学士/工学士研究

临床试验材料和耗材市场规模：按类型

• 市场概况
• 小分子
• 生物製药
• 医疗设备

临床试验材料与耗材市场规模：依治疗领域

• 市场概况
• 肿瘤学
• 感染疾病
• 神经病学
• 代谢紊乱
• 免疫学
• 心臟病学
• 遗传疾病
• 其他治疗领域

临床试验材料和耗材市场规模：按最终用户划分

• 市场概况
• 製药和生物技术公司
• 合约研究组织（CRO）
• 医疗设备公司

临床试验材料及耗材市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
• 收益与前一年同期比较（2022-2024）

主要企业简介

• Lonza Group
• Catalent, Inc.
• Piramal Pharma Solutions
• Almac Group
• Parexel International
• Eurofins Scientific
• Marken（A Subsidiary of UPS）
• Thermo Fisher Scientific, Inc.
• Sharp Services, LLC
• PCI Pharma Services
• Nuvisan
• Celerion
• WuXi AppTec
• Recipharm AB
• Tunnell Consulting
• Aesica Pharmaceuticals
• Boehringer Ingelheim
• Kendle International（Now a part of INC Research）
• Syneos Health
• Vetter Pharma

结论和建议

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 3.84 billion in 2024 to USD 8.12 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The management of clinical trial supplies is critical to avert issues such as inventory expiration and overproduction, especially as drug detection costs rise. Effective supply chain management is essential in clinical research, addressing infrastructure limitations and stringent regulations. Key market drivers include the expansion and growing complexity of clinical trials. Clinical trial supplies encompass various instruments like infusion pumps, nebulizers, and syringe needles, pivotal for evaluating and treating diseases across cardiovascular, neurological, oncological, and pulmonary fields. Outsourcing of supplies by drug developers and manufacturers is increasing, ensuring timely delivery to investigator sites. Additionally, technological advancements, strategic growth among solution providers, and a rise in patent expirations have fueled demand for clinical trial materials, contributing to robust market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segmental Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is significantly driven by the increasing participation of patients in clinical trials within emerging economies such as China, India, and South Korea. The lower costs associated with conducting clinical trials in these nations-28% cheaper before tax incentives and a remarkable 60% less expensive after tax incentives compared to the United States-have attracted pharmaceutical companies seeking to optimize their research expenditures. This trend has also led to a shift in clinical trial locations, particularly for rare diseases. Furthermore, advancements in technology and data analytics contribute to improved decision-making in clinical trials, prompting the pharma and biotech sectors to invest in outsourcing innovative solutions that enhance trial processes and supply chains in these developing markets.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces considerable restraints primarily due to the high attrition rates of drug candidates during development, which lead to immense research and development costs. The complexities associated with R&D for rare diseases often require specialized personnel to conduct clinical trials, further complicating the process. For instance, only 7 out of 100 cancer drugs that reach clinical trials ultimately gain regulatory approval, with most drug candidates failing before this stage. Additionally, the entire journey from drug discovery to FDA approval can span 10-15 years and incur costs around USD 2.6 billion, with less than 12% of candidates reaching Phase clinical trials successfully, posing significant challenges to market expansion.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable trend towards the increased utilization of biologics and temperature-sensitive medications, with approximately 35% of late-phase pharmaceutical drugs classified as biologics, alongside 38% being temperature-sensitive. This shift is largely attributed to the advantages biologics offer, including fewer side effects compared to traditional pharmaceuticals. With the expectation that the prevalence of biologics will continue to rise, there is a corresponding surge in demand for advanced cold chain logistics and storage solutions to ensure the efficacy and safety of these sensitive materials during clinical trials, thereby shaping the future landscape of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Supply Chain Analysis
• Technology Analysis
• Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2025-2032)

• Market Overview
• Logistics & Distribution
• Storage & Retention
• Packaging, Labelling & Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV
• BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2025-2032)

• Market Overview
• Small-Molecules
• Biologic Drugs
• Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Diseases
• Neurology
• Metabolic Disorders
• Immunology
• Cardiology
• Genetic Diseases
• Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical And Biotechnology Companies
• Contract Research Organisations (CRO's)
• Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2025-2032)

• North America (Service, Phase, Type, Therapeutic Area, End User)
  • US
  • Canada
• Europe (Service, Phase, Type, Therapeutic Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Type, Therapeutic Area, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (A Subsidiary of UPS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvisan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunnell Consulting
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesica Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kendle International (Now a part of INC Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations